• Privacy Policy
  • Terms Of Service
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
Forex trading, free forex education | Forex.ca

 

  • Home
  • Forex News
  • Stock News
  • For Beginners
  • Market Analysis
  • Trading Strategies
  • Real Time Stock Update
  • Shop
News Ticker
  • [ September 30, 2025 ] Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders Stock News
  • [ September 30, 2025 ] Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary Stock News
  • [ September 30, 2025 ] Tesla (TSLA) Share Price Rises Ahead of Earnings Report Forex News
  • [ September 29, 2025 ] Accenture: The Best Way To Play AI's Next Phase Stock News
  • [ September 29, 2025 ] Growth & Total Return Weekly Chat Stock News
Home2023

Year: 2023

Stock News

Orion Office Stock Is Dirt Cheap With Upside Potential (NYSE:ONL)

January 10, 2023 admin 0

cemagraphics Orion Office REIT (NYSE:ONL) hasn’t done very well from a share price perspective since being spun-off from Realty Income Corp. (O) fourteen months ago. Understandably, the market is rather weary around office properties, especially […]

Stock News

German gas storage operators optimistic for next winter By Reuters

January 10, 2023 admin 0

© Reuters. FILE PHOTO: The ‘Hoegh Esperanza’ Floating Storage and Regasification Unit (FSRU) is anchored during the opening of the LNG (Liquefied Natural Gas) terminal in Wilhelmshaven, Germany, December 17, 2022. Michael Sohn/Pool via REUTERS/File […]

Stock News

Illumina challenges EU order to keep Grail separate By Reuters

January 10, 2023 admin 0

© Reuters. FILE PHOTO: Illumina’s global headquarters is pictured in San Diego, California, U.S., November, 28, 2022. REUTERS/Mike Blake/File Photo By Foo Yun Chee BRUSSELS (Reuters) – U.S. life sciences company Illumina (NASDAQ:) on Tuesday […]

Posts navigation

« 1 … 3,769 3,770 3,771 … 4,581 »

For Beginners


Categories

  • Forex News
  • Stock News
No Picture
Stock News

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

September 30, 2025 0

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

Stock News

Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary

September 30, 2025 0

Follow Summary The second quarter of 2025 was defined by several key policies from the new Trump administration, including tariffs/trade, immigration, and taxes. The fund returned 1.88% in the second quarter versus the ICE BoA […]

Latest news
  • Tesla (TSLA) Share Price Rises Ahead of Earnings Report
    September 30, 2025 0
  • Nikkei 225 Rises Following Resignation of Prime Minister Shigeru Ishiba
    September 8, 2025 0
Random News
  • U.S. pension funds may pour $400 billion into stocks, lifting virus-hit markets: JP Morgan By Reuters
    April 4, 2020 0
  • Earnings Season: Starting From A Place Of Resilience
    October 12, 2024 0
  • Meta Platforms Stock: Leadership Vacuum Will Pass (NASDAQ:META)
    September 17, 2022 0
Email Inquiries to: warp1@sympatico.ca
  • No Picture
    Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders
    September 30, 2025 0
  • Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary
    September 30, 2025 0
Pages
  • Contact Us
  • Home
  • Privacy Policy
  • Real Time Stock Update
  • Shop
  • Terms Of Service

© Copyright 2020-2023 Forex.ca

Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.